SimonMed Brings Arizona’s First AI-Powered Pristina Recon DL Mammography Technology to Scottsdale
SimonMed, a leading company in radiology, imaging and longevity technology, today announced that it will become the first imaging provider in Arizona to introduce Pristina Recon DL, GE HealthCare’s advanced AI-powered mammography image reconstruction technology.
The software will be integrated into GE HealthCare’s Senographe Pristina mammography system at SimonMed’s Scottsdale Mountain View location, with the first patient examinations anticipated in early October, coinciding with Breast Cancer Awareness Month.
Pristina Recon DL uses two deep learning models to enhance image quality and improve the visualization of subtle details that may be important in identifying breast cancer. The technology delivers sharp, clear 3D mammography images without increasing radiation dose or changing the patient exam experience.
Pristina Recon DL uses two deep learning models to enhance image quality and improve the visualization of subtle details that may be important in identifying breast cancer. The technology delivers sharp, clear 3D mammography images without increasing radiation dose or changing the patient exam experience.
“Early detection saves lives, and our mission at SimonMed is to bring the most advanced, life-saving technology to the communities we serve without creating additional financial barriers for patients,” said John Simon, MD, Founder and Chief Executive Officer of SimonMed. “By bringing this technology to Arizona first, we’re giving our radiologists even clearer images to help identify subtle signs of breast cancer and providing referring physicians with the advanced imaging they rely on to care for their patients. And we’re making these advances available at no additional cost. That’s what innovation should look like in healthcare.“
In a GE HealthCare preference study, radiologists preferred the overall image quality of Pristina Recon DL in 99.11% of image evaluations compared to previous digital breast tomosynthesis (DBT) reconstruction. Pristina Recon DL shows superior performance in the detection of microcalcification clusters and masses in a trial with modeled clinical data.
For referring providers, the technology represents another advancement in the imaging and diagnostic expertise available to their patients. By providing radiologists with sharp, clear 3D mammography images, SimonMed aims to support the identification and evaluation of subtle findings, helping physicians make informed decisions about patient care and recommended next steps.
“At GE HealthCare, we’re focused on developing innovations that give clinicians the clarity and confidence they need to deliver exceptional patient care,” said Victoria Daly, VP, Women’s Health, US and Canada, GE HealthCare. “By implementing Pristina Recon DL, SimonMed is bringing advancements in deep learning image reconstruction to women in Arizona, combining exceptional image quality with an efficient, patient-centered mammography experience. Together, we’re helping expand access to innovative solutions that can help support early detection of breast cancer.“
Since 2019, SimonMed has incorporated AI-assisted breast cancer detection into all of its 3D mammograms at no additional cost to patients. These tools support subspecialty-trained radiologists by highlighting potentially suspicious findings that may warrant closer evaluation. The introduction of Pristina Recon DL builds on SimonMed’s longstanding commitment to applying artificial intelligence in breast imaging.
To learn more about SimonMed’s mammography services or schedule an appointment, visit simonmed.com.
About SimonMed
Headquartered in Scottsdale, Arizona, SimonMed is one of the largest outpatient diagnostic imaging and health technology providers in the United States. SimonMed operates more than 175 centers across 10 states and is supported by a nationwide team of more than 300 subspecialty-trained, board-certified radiologists. SimonMed provides the full spectrum of diagnostic imaging services from X-ray to complex Cardiac MRI and is a recognized leader in the clinical use of artificial intelligence.
SimonMed Longevity is a division focused on proactive health. It offers whole-body MRI and preventive, multi-modality screening designed to help patients establish a baseline of their health, track changes over time, and identify potential risk earlier—when informed action may help prevent or delay disease.
National Breast Cancer Foundation, Inc. (n.d.). Breast cancer facts & statistics. National Breast Cancer Foundation.
https://www.nationalbreastcancer.org/breast-cancer-facts/
Preference study performed on 140 study cases with eight MQSA-approved radiologists, trained on clinical image quality by ACR, comparing Pristina Recon DL to ASiR V1. Overall image quality preference score was 99.11%. Conspicuity of microcalcifications was preferred in 93.67% of image evaluations. Pristina Recon DL is an optional AI-based reconstruction solution of Senographe Pristina 3D.
